Gene discovery links cancer cell 'recycling' system to potential new therapy
2014-05-02
(Press-News.org) University of Rochester scientists have discovered a gene with a critical link to pancreatic cancer, and further investigation in mice shows that by blocking the gene's most important function, researchers can slow the disease and extend survival.
Published online by Cell Reports, the finding offers a potential new route to intrude on a cancer that usually strikes quickly, has been stubbornly resistant to targeted therapies, and has a low survival rate. Most recent improvements in the treatment of pancreatic cancer, in fact, are the result of using different combinations of older chemotherapy drugs.
The research led by Hartmut "Hucky" Land, Ph.D., and Aram F. Hezel, M.D., of UR Medicine's James P. Wilmot Cancer Center, identifies a new target in the process of garbage recycling that occurs within the cancer cell called autophagy, which is critical to pancreatic cancer progression and growth.
Autophagy is derived from the Greek roots "auto" (self) and "phagein" (to eat), and is an intracellular digestive process that allows cells to survive under stress. During a cell's transformation from normal to malignant, autophagy speeds up to keep pace with rapid cellular changes and a tumor's quest to grow. The newly discovered PLAC-8 gene sustains the highly active recycling process, as it removes faulty proteins and organelles and degrades them into reusable building blocks during cancer progression.
"What makes this an exciting opportunity is that the gene we're studying is critical to the cancer cell's machinery but it is not essential to the function of normal cells," said Land, chair of Biomedical Genetics at the University of Rochester School of Medicine and Dentistry and director of research at Wilmot. "By targeting these types of non-mutated genes that are highly specific to cancer, we are looking for more effective ways to intervene."
The Cell Reports study underlines Wilmot's overall unique approach to cancer research. Rather than investigate single faulty genes linked to single subtypes of cancer, Rochester scientists have identified a larger network of approximately 100 non-mutated genes that cooperate and control the shared activities of many cancers. While investigating this larger gene network, Land and Hezel focused on PLAC-8.
Moreover, the team found that by inactivating PLAC-8 in mice and shutting down autophagy, they could significantly slow cancer's progression. The relevance of PLAC-8 may also extend to other tumors – lung, colon, and liver, for example -- that share key genetic changes such as KRAS and p53 mutations that are present in the majority of pancreatic cancers. The breadth of these findings is an area of ongoing study in the Land and Hezel labs.
"PLAC-8 and its job within the cancer cell of accelerating recycling suggests new points of attack and what we all hope will be opportunities to identify and develop new treatments," said Hezel, vice chief of Wilmot's Division of Hematology and Oncology and a UR associate professor. "Our data showing PLAC 8's role in autophagy has great potential because while there are other drugs being evaluated to inhibit autophagy, not all of them target proteins specifically important to this process in tumors."
The role of autophagy in cancer is gaining attention. Clinical testing of new therapies is taking place at the same time that a new basic understanding of this process and how it functions in pancreatic cancer is emerging.
The New England Journal of Medicine recently published a commentary on autophagy's role in pancreatic cancer and the possible implications for clinical trials. And the Rochester paper offers explanations for some discrepancies seen in previous studies; Cell Reports invited Land and Hezel to write an online blog to accompany their article, describing their data in light of the scientific questions.
INFORMATION:
The National Institutes of Health funded this investigation with separate awards to Hezel and Land. Hezel is also supported by the Edelman-Gardner Cancer Research Foundation in Hilton, N.Y.; Pancreatic Cancer Association of Western New York; and the annual Michael F. Contestabile Memorial Golf Tournament to support cancer research at Wilmot.
ELSE PRESS RELEASES FROM THIS DATE:
Blood pressure control, lifestyle changes key to preventing subsequent strokes
2014-05-02
Stroke survivors should control their blood pressure, cholesterol and weight and do moderate physical activity regularly to avoid having another stroke, according to an American Heart Association/American Stroke Association scientific statement.
They should also receive other evidence-based therapy specific to their individual health, which may include aspirin therapy or a surgical procedure to keep neck arteries open.
The statement, "Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack (TIA)," is published in the American Heart ...
Amphibians in a vise: Climate change robs frogs, salamanders of refuge
2014-05-02
By hightailing it to nearby ponds and shallow waterways, frogs and salamanders have – until now – had a way to evade exotic trout introduced to the West's high-mountain lakes for recreational fishing.
A warming climate, however, will dry up some of the places where amphibians and their young have found refuge. Researchers in the May 1 issue of Frontiers in Ecology and the Environment write about this challenge and a novel combination of tools that could help land managers, biologists, fishing enthusiasts and other citizens weigh where amphibians are in the most need of ...
Remodelling damaged nuclei
2014-05-02
Scientists at the University of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing. The results are published in the journal Science.
Around 150 people worldwide are known ...
'Achilles heel' of pancreatic cancer identified
2014-05-02
WASHINGTON — A research team at Georgetown Lombardi Comprehensive Cancer Center reports that inhibiting a single protein completely shuts down growth of pancreatic cancer, a highly lethal disease with no effective therapy.
Their study, to be published May 6th in Science Signaling, demonstrates in animal models and in human cancer cells that while suppressing Yes-associated protein (Yes) did not prevent pancreatic cancer from first developing, it stopped any further growth.
"We believe this is the true Achilles heel of pancreatic cancer, because knocking out Yes crushes ...
Decoding the chemical vocabulary of plants
2014-05-02
Stanford, CA—Plants spend their entire lifetime rooted to one spot. When faced with a bad situation, such as a swarm of hungry herbivores or a viral outbreak, they have no option to flee but instead must fight to survive. What is the key to their defense? Chemistry.
Thanks to this ongoing conflict, plants have evolved into amazing chemists, capable of synthesizing tens of thousands of compounds from thousands of genes. These chemicals, known as specialized metabolites, allow plants to withstand transient threats from their environment. What's more, some of the same compounds ...
A new syndrome caused by mutations in AHDC1
2014-05-02
HOUSTON – (May 1, 2014) -- A team of researchers led by Baylor College of Medicine have identified the gene underlying a newly recognized genetic syndrome that has symptoms of sleep apnea, delayed speech and hyptonia, or generalized upper body weakness.
The study published online today in the American Journal of Human Genetics.
The Baylor researchers first studied a patient from Australia with these symptoms who had been seen by many doctors and had multiple diagnostic tests, without any diagnosis.
Although there was no family history of the disease, the researchers ...
How do our cells move? Liquid droplets could explain
2014-05-02
'Cell migration' is a broad term for all the processes associated with the movement of cells from one location to another. It lies at the core of biological processes like embryonic development, immune responses and wound healing, but also autoimmune diseases and metastasis of cancerous cells. Cell migration is achieved through the movement of the cell's membrane, which is powered by the action of a protein network inside the cell. However, this interaction is affected by the cell's overall shape, but exactly how this takes place is unclear. Publishing in Current Biology, ...
Expensive helmets do not improve outcomes in healthy babies with positional skull flattening
2014-05-02
Babies who have skull deformation because they lie in the same position most of the time do not benefit from wearing a corrective helmet, finds research published today on bmj.com.
There was no meaningful difference in skull shape at the age of two years between children treated with therapy helmet and those who received no active treatment. Both groups showed similar improvements although only a quarter made a full recovery to a normal head shape, according to the team of researchers based in The Netherlands.
Around one baby in five under the age of six months develops ...
10-year study shows 'Lethal Factor' could be X-factor for new anthrax vaccine
2014-05-02
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine.
Anthrax is a potentially lethal disease caused by a bacterium called Bacillus anthracis. The bacteria produce spores that when inhaled, ingested or absorbed into the skin release toxins. When anthrax affects the lungs or intestines it can cause death within a few days whilst infection of the skin (cutaneous anthrax) is less dangerous.
Infection can occur from contact with infected livestock, meat or hides, but most people know about anthrax from ...
Breaking up water: Controlling molecular vibrations to produce hydrogen
2014-05-02
Natural gas (methane) can be converted into hydrogen (H2), which is used in clean energy, synthetic fertilizers, and many other chemicals. The reaction requires water and a nickel catalyst. Methane and water molecules attach on the catalyst's surface, where they dissociate into their atomic components. These then recombine to form different compounds like H2 and CO. Previous research has focused mainly on understanding how methane dissociates, but experimental constraints have limited research into water dissociation. Publishing in Science, EPFL scientists have used lasers ...